3GCo
Active3GCo is a financial institution; the bankruptcy model is trained on trading and manufacturing companies and does not apply here. The 2025 annual accounts show equity of €1.24M and a net result of €-31k. Equity remains stable across the filed fiscal years (±0.6% per year). Its solvency ranks better than 27% of 2386 sector peers (fiscal year 2025). The company has been active since 2011 and the Belgian State Gazette contains no insolvency or warning signals.
Signals
Three signals. The signal on the left, the evidence on the right.
○neutral
neutral · Latest accounts filed on time
The financial year that closed on 30-06-2025 was due by 31-01-2026 and was filed on 31-01-2026, 0 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
on the day
2024
1 d early
2023
on the day
2022
4 d early
2021
on the day
2020
1 d late
2019
21 d late
← before the deadline
after the deadline →
neutral · The next deadline is still running
The next financial year closes on 30-06-2026 and is due by 31-01-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
30-06-2026 close16-09-2026 today31-01-2027 deadline
Financials · fiscal year 2025, full schema
Equity
€1.24M▼ 2.4%
2024 · €1.27M
2019: €1.22M
2020: €1.22M
2021: €1.27M
2022: €1.26M
2023: €1.29M
2024: €1.27M
2019 → 2025
Net result
€-31k▼ 125%
2024 · €-14k
2019: €-29k
2020: €1k
2021: €45k
2022: €18k
2023: €49k
2024: €-14k
2019 → 2025
Total assets
€3.66M▼ 1.0%
2024 · €3.69M
2019: €3.62M
2020: €3.62M
2021: €3.71M
2022: €3.66M
2023: €3.70M
2024: €3.69M
2019 → 2025
Solvency
34.0%▼ 0.5pp
2024 · 34.5%
2019: 33.7%
2020: 33.8%
2021: 34.1%
2022: 34.4%
2023: 34.8%
2024: 34.5%
2019 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20212022202320242025Trend
Turnover€254k-€227k▼ 10.6%
Equity€1.27M-€1.26M▼ 0.5%€1.29M▲ 2.3%€1.27M▼ 1.1%€1.24M▼ 2.4%
Operating result€137k-€111k▼ 19.3%€139k▲ 25.7%€79k▼ 43.3%€61k▼ 22.5%
Net result€45k-€18k▼ 59.4%€49k▲ 167%€-14k€-31k▼ 125%
Result per fiscal year
Operating resultNet result
The operating result has fallen two years in a row; 2025 is 23% below 2024 and is the lowest year so far.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €3.66M
Fixed assets
€3.50M=
Current assets
€156k▼ 18.5%
Equity and liabilities €3.66M
Equity
€1.24M▼ 2.4%
Debt
€2.41M▼ 0.2%
The debt ratio rises from 65.5% to 66.0%: equity shrinks faster than debt is paid down.
Key figures and ratios
Solvency
34.0%▼
2024 · 34.5%
ROE
-2.5%▼
2024 · -1.1%
ROA
-0.8%▼
2024 · -0.4%
Debt
€2.41M▼
2024 · €2.42M
Debt ≤ 1 year
€418k▲
2024 · €412k
Debt > 1 year
€2.00M▼
2024 · €2.01M
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet
Code20242025
Assets
Total assets20/58€3.69M€3.66M▼
Fixed assets21/28€3.50M€3.50M=
Tangible fixed assets22/27€982€517▼
Furniture and vehicles24€982€517▼
Financial fixed assets28€3.50M€3.50M=
Current assets29/58€192k€156k▼
Amounts receivable within one year40/41€178k€149k▼
Trade receivables40€175k€148k▼
Other amounts receivable41€3k€433▼
Cash at bank and in hand54/58€13k€7k▼
Deferred charges and accrued income490/1€844€426▼
Equity and liabilities
Total equity and liabilities10/49€3.69M€3.66M▼
Equity10/15€1.27M€1.24M▼
Contributions10/11€1.16M€1.16M=
Outside capital11€1.16M€1.16M=
Other1109/19€1.16M€1.16M=
Profit (loss) carried forward14€116k€85k▼
Amounts payable17/49€2.42M€2.41M▼
Amounts payable after more than one year17€2.01M€2.00M▼
Financial debts170/4€2.01M€2.00M▼
Amounts payable within one year42/48€412k€418k▲
Financial debts43€4k€4k▼
Credit institutions430/8€4k€4k▼
Trade debts44€13k€20k▲
Suppliers440/4€13k€20k▲
Taxes, remuneration and social security45€28k€27k▼
Taxes450/3€28k€27k▼
Other amounts payable47/48€367k€367k=
Accrued charges and deferred income492/3€10-
Income statement
Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€1k€465▼
Other operating charges640/8€1k€752▼
Gross operating margin9900€81k€62k▼
Operating profit (loss)9901€79k€61k▼
Financial charges65/66B€92k€92k▼
Recurring financial charges65€92k€92k▼
Profit (loss) for the period before taxes9903€-14k€-31k▼
Income taxes67/77€190-
Profit (loss) for the period9904€-14k€-31k▼
Profit (loss) for the period to be appropriated9905€-14k€-31k▼
Appropriation of the result
Profit (loss) to be appropriated9906€116k€85k▼
Profit (loss) brought forward from the previous period14P€129k€116k▼
The notes to these accounts (6 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
31-01
NBB filing
Annual accounts filed
fiscal year 2025 · full schema
2025
30-06
Financial
Weakest financial yearnet €-31k
Net result drops to €-31k, the lowest in the series.
30-01
NBB filing
Annual accounts filed
fiscal year 2024 · full schema
2024
31-01
NBB filing
Annual accounts filed
fiscal year 2023 · full schema
2023
30-06
Financial
Highest result since 2019net €49k ▲167%
Operating result €139k, net result €49k, both a record.
27-01
NBB filing
Annual accounts filed
fiscal year 2022 · full schema
2022
31-01
NBB filing
Annual accounts filed
fiscal year 2021 · full schema
2021
01-02
NBB filing
Annual accounts filed
fiscal year 2020 · full schema · 1 day late
2020
30-06
Financial
Back to profitnet €1k
Net result €1k after one loss-making year.
21-02
NBB filing
Annual accounts filed
fiscal year 2019 · full schema · 21 days late
2019
26-02
NBB filing
Annual accounts filed
fiscal year 2018 · full schema · 26 days late
2018
28-02
NBB filing
Annual accounts filed
fiscal year 2017 · full schema · 28 days late
2017
14-02
NBB filing
Annual accounts filed
fiscal year 2016 · full schema · 14 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
no sitting director, no change since 2021
We have established no sitting directors for this company. We derive directors from published Gazette acts; while there are none, or none read, nothing appears here. That does not mean the company has none: the CBE keeps its own list of function holders, which we do not read.
16-06-2021
Resigned as Manager
Location & real-estate footprint
Registered office, Wavre · 1 establishment unit since 2011
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Rue des Templiers 351301 WavreGround area
3,456 m²
Building footprint
291 m²
Volume, LiDAR
2,190 m³
2 parcels, Wallonia · tallest building 11.9 m, ±3 floors. Linked by address, not a title deed.
1 establishment unit
3GCo
since 20112.197.845.992
2 parcels
Wallonia
2
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 25006B0105/00W004 | Wallonia | 1,931 m² | 1 · 147 m² | 8.0 m · 2 fl. |
| 25038C0149/00M000 | Wallonia | 1,525 m² | 1 · 143 m² | 11.8 m · 3 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1 · via establishment units: 1
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
GODEX
BE 0678.857.666
Nieuwerkerken (Limb.) · Eq €1.24M
Foronex Groep
BE 0770.489.212
Wielsbeke · Eq €1.24M
BRONCKX
BE 0808.711.071
Liège · Eq €1.24M
BURO 78
BE 0807.968.230
Wichelen · Eq €1.24M
ARLI
BE 0474.773.131
Wevelgem · Eq €1.24M
Of 24,726 companies in sector 64210 we hold annual accounts for 19,748. 12,184 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded25-03-2011
Fiscal year end30-06
Activities, NACEBEL
64200Holdings
64210Activities of holding companies
21100Manufacture of basic pharmaceutical products and pharmaceutical preparations
21201Manufacture of basic pharmaceutical products and pharmaceutical preparations
21209Manufacture of basic pharmaceutical products and pharmaceutical preparations
46150Agents in the wholesale of furniture, household goods and hardware
46460Wholesale of pharmaceutical and medical goods
Sources
Crossroads Bank for EnterprisesNational Bank · 14 filingsAddress and cadastre registers
Data from official sources, last processed on 14-09-2026. Scores and ratios are computed by Checked and are not a credit decision.